TL;DR: A huge genetics study links two brain-signalling genes (CADM2 and GRM3) to trying and frequently using cannabis; it doesn’t say anyone is “destined” to overuse, but it nudges the conversation toward risk, impulsivity, and mental health—useful context for making intentional choices.
What the research actually shows: Researchers analysed genetic data from 131,895 people and found that variants near CADM2 (often tied to impulsivity and risk‑taking) and GRM3 (a glutamate receptor involved in brain plasticity) were more common among people who had tried cannabis and, for CADM2, among those who used it more frequently. They also saw genetic overlap with traits like ADHD, depression, and risk‑taking, plus physical conditions in broader datasets. Importantly, genetics explained only a modest slice of behaviour—context and environment still matter a lot.
Healthy scepticism corner: this is correlation, not destiny. GWAS links DNA “neighbourhoods” to traits; they don’t prove a direct cause, and most effects are small. Some findings were first shared as a preprint and then published, which is good for transparency, but we still need replication across ancestries and objective measures of use (not just self‑report).
So my friend, what does this mean for your wellness journey right now?
- Make it intentional. If you do use cannabis (for example, a low‑THC product on an occasional evening), pair it with a simple check‑in: mood, sleep quality, and reasons for use. Patterns—especially “I reach for it when I’m stressed or bored”—are more actionable than labels.
- Know your tendencies. If you lean impulsive or are navigating anxiety, low mood, or attention challenges, this research suggests extra care with frequency and context. Consider setting gentle guardrails (e.g., planned “off” days, dose caps, or substituting a non‑intoxicating wind‑down like chamomile, breathwork, or magnesium‑rich foods). Evidence for these supports is mixed but generally low risk when used appropriately.
- Keep mental health centred. A low percentage of people who try cannabis may develop some level of cannabis use disorder; most do not, but if usage starts to feel less in your control, a GP or specialist clinic can help you recalibrate early.
Is this actionable now or later?
Both. You can apply the “intentional use” lens today. The more personalised, genetics‑informed guidance will unfold over time as polygenic tools mature and are validated ethically and clinically. For now, treat this as a nudge toward mindful routines, not a verdict written in your DNA.
Educational only; not medical advice.






